Skip to main navigation Skip to search Skip to main content

Intravenous β-endorphin administration fails to alter hypothalamic blood flow in rats expressing normal or reduced nihic oxide synthase activity

  • Zoltán Benyó
  • , Csaba Szabó
  • , Mária H. Velkei
  • , Béla Bohus
  • , Michael Wahl
  • , Péter Sándor

Research output: Contribution to journalArticlepeer-review

Abstract

-Endorphin (β-END) significantly contributes to the maintenance of hypothalamic blood flow (HBF) autoregulation during hemorrhagic hypotension in rats. Recently, several natural and synthetic opioid peptides were reported to induce nitric oxide (NO)-mediated dilation in the cerebrovascular bed. In the present study, the effect of β-END was studied on HBF and hypothalamic vascular resistance (HVR) in vehicle-treated control rats and in rats after the pharmacological inhibition of the NO synthesis by chronic oral application of N(G)-nitro-L-arginine methyl ester. Intravenous β-END administration faired to alter HBF or HVR either in control or in NO-blocked animals, and its transient hypotensive effect was not inhibited by NO blockade, indicating that β-END may not have NO-mediated vasodilator effect in the hypothalamic or in the systemic circulation.

Original languageEnglish (US)
Pages (from-to)733-736
Number of pages4
JournalPeptides
Volume17
Issue number4
DOIs
StatePublished - 1996
Externally publishedYes

Keywords

  • -Endorphin
  • Cerebral blood flow autoregulation
  • Hypertension
  • Hypothalamus
  • N(G)-Nitro-L-arginine methyl ester (L-NAME)
  • Nitric oxide synthase blockade
  • Rat

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Intravenous β-endorphin administration fails to alter hypothalamic blood flow in rats expressing normal or reduced nihic oxide synthase activity'. Together they form a unique fingerprint.

Cite this